Bruce Booth
Atlas Venture Partner
investment range
$500k - $5.0m
sweet spot
$2.0m
Bruce Booth's Past Investments (31)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Kymera Therapeutics | Series A | $30M (Lead) | Oct 2017 | |
| Rodin Therapeutics | Series C | $27M (Lead) | Sep 2017 | |
| Bicycle Therapeutics | Series B | $52M | Jun 2017 | |
| Magenta Therapeutics | Series B | $50M | May 2017 | |
| Miragen Therapeutics | Series C | $40.7M | Feb 2017 | |
| Magenta Therapeutics | Series A | $48.5M (Lead) | Nov 2016 | |
| Avrobio | Series A | $25M (Lead) | Aug 2016 | |
| Rodin Therapeutics | Series B | $17.3M | Jan 2016 | |
| Miragen Therapeutics | Series C | $41M | Nov 2015 | |
| UNUM Therapeutics | Series B | $65M | Jun 2015 |
Bruce Booth's Media
No media found for Bruce Booth.